Bookbot

Making PCR

A Story of Biotechnology

Autor*innen

Parameter

  • 198 Seiten
  • 7 Lesestunden

Mehr zum Buch

This account offers a captivating look into the invention of the polymerase chain reaction (PCR), a groundbreaking biotech discovery that revolutionized molecular biology. PCR enhances scientists' capabilities to identify and manipulate genetic materials, enabling the rapid reproduction of millions of copies of specific DNA segments, thus transforming scarce genetic material into an abundant resource for experimentation. The narrative delves into the biotechnology culture that developed at Certus Corporation during the 1980s, examining the interplay of scientific, technical, social, economic, political, and legal factors that shaped this field. It features interviews with key figures involved in the creation of PCR, including Kary Mullis, the Nobel laureate credited with its discovery, along with a team of innovative scientists and business leaders. The book illustrates how a unique practice emerged through the collaboration of diverse individuals, their work environment, and the invention itself. Critics praise the work for its detailed exploration of the discovery process and its ethnographic approach to understanding the realities of scientific work in the lab, raising important questions about the nature of innovation in biomedical research.

Buchkauf

Making PCR, Paul Rabinow

Sprache
Erscheinungsdatum
1996
product-detail.submit-box.info.binding
(Paperback)
Wir benachrichtigen dich per E-Mail.

Lieferung

  • Gratis Versand ab 14,99 € in ganz Deutschland! Mehr Infos.

Zahlungsmethoden

Keiner hat bisher bewertet.Abgeben

Titel
Making PCR
Untertitel
A Story of Biotechnology
Sprache
Englisch
Autor*innen
Paul Rabinow
Erscheinungsdatum
1996
Einband
Paperback
Seitenzahl
198
ISBN10
0226701476
ISBN13
9780226701479
Reihe
Beschreibung
This account offers a captivating look into the invention of the polymerase chain reaction (PCR), a groundbreaking biotech discovery that revolutionized molecular biology. PCR enhances scientists' capabilities to identify and manipulate genetic materials, enabling the rapid reproduction of millions of copies of specific DNA segments, thus transforming scarce genetic material into an abundant resource for experimentation. The narrative delves into the biotechnology culture that developed at Certus Corporation during the 1980s, examining the interplay of scientific, technical, social, economic, political, and legal factors that shaped this field. It features interviews with key figures involved in the creation of PCR, including Kary Mullis, the Nobel laureate credited with its discovery, along with a team of innovative scientists and business leaders. The book illustrates how a unique practice emerged through the collaboration of diverse individuals, their work environment, and the invention itself. Critics praise the work for its detailed exploration of the discovery process and its ethnographic approach to understanding the realities of scientific work in the lab, raising important questions about the nature of innovation in biomedical research.